Global Blood Therapeutics' Series A Round

Global Blood Therapeutics raised a round of funding on June 14, 2012. Investors include Third Rock Ventures.

Global Blood Therapeutics (GBT) is a biopharmaceutical company developing novel small molecule therapeutics for the treatment of severe blood disorders. The company is addressing serious, non-malignan…

Articles about Global Blood Therapeutics' Series A Round: